The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Annual report to the nation on the status of cancer, part 1: National cancer statistics
Open accessAbstract
Background: The American Cancer Society, the Centers for Disease Control and Prevention, the National Cancer Institute, and the North American Association of Central Cancer Registries collaborate to provide annual updates on cancer occurrence and trends in the United States. Methods: Data on new cancer diagnoses during 2001–2018 were obtained from the North American Association of Central Cancer Registries’ Cancer in North America Incidence file, which is comprised of data from Centers for Disease Control and Prevention‐funded and National Cancer Institute‐funded, population‐based cancer registry programs. Data on cancer deaths during 2001–2019 were obtained from the National Center for Health Statistics' National Vital Statistics System. Five‐year average incidence and death rates along with trends for all cancers combined and for the leading cancer types are reported by sex, racial/ethnic group, and age. Results: Overall cancer incidence rates were 497 per 100,000 among males (ranging from 306 among Asian/Pacific Islander males to 544 among Black males) and 431 per 100,000 among females (ranging from 309 among Asian/Pacific Islander females to 473 among American Indian/Alaska Native females) during 2014–2018. The trend during the corresponding period was stable among males and increased 0.2% on average per year among females, with differing trends by sex, racial/ethnic group, and cancer type. Among males, incidence rates increased for three cancers (including pancreas and kidney), were stable for seven cancers (including prostate), and decreased for eight (including lung and larynx) of the 18 most common cancers considered in this analysis. Among females, incidence rates increased for seven cancers (including melanoma, liver, and breast), were stable for four cancers (including uterus), and decreased for seven (including thyroid and ovary) of the 18 most common cancers. Overall cancer death rates decreased by 2.3% per year among males and by 1.9% per year among females during 2015–2019, with the sex‐specific declining trend reflected in every major racial/ethnic group. During 2015–2019, death rates decreased for 11 of the 19 most common cancers among males and for 14 of the 20 most common cancers among females, with the steepest declines (>4% per year) reported for lung cancer and melanoma. Five‐year survival for adenocarcinoma and neuroendocrine pancreatic cancer improved between 2001 and 2018; however, overall incidence (2001–2018) and mortality (2001–2019) continued to increase for this site. Among children (younger than 15 years), recent trends were stable for incidence and decreased for mortality; and among, adolescents and young adults (aged 15–39 years), recent trends increased for incidence and declined for mortality. Conclusions: Cancer death rates continued to decline overall, for children, and for adolescents and young adults, and treatment advances have led to accelerated declines in death rates for several sites, such as lung and melanoma. The increases in incidence rates for several common cancers in part reflect changes in risk factors, screening test use, and diagnostic practice. Racial/ethnic differences exist in cancer incidence and mortality, highlighting the need to understand and address inequities. Population‐based incidence and mortality data inform prevention, early detection, and treatment efforts to help reduce the cancer burden in the United States.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Pearson-Stuttard, J., Zhou, B., Kontis, V., Bentham, J., Gunter, M. J., & Ezzati, M. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30150-5 · Cited by 307
RetractedPearson-Stuttard, J., Zhou, B., Kontis, V., Bentham, J., Gunter, M. J., & Ezzati, M. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30366-2 · Cited by 265
RetractedSiegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21708 · Cited by 17,196
Self-citationBody Fatness and Cancer — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., & Straif, K. (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1606602 · Cited by 3,596
WHO Classification: Tumours of the Haematopoietic and Lymphoid Tissues (2008)
(2015) · Postgraduate Haematology · doi:10.1002/9781118853771.ch51 · Cited by 3,290
Breast cancer statistics, 2019
DeSantis, C. E., Ma, J., Gaudet, M. M., Newman, L. A., Miller, K. D., Goding Sauer, A., Jemal, A., & Siegel, R. L. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21583 · Cited by 3,114
Self-citationEverolimus for Advanced Pancreatic Neuroendocrine Tumors
Yao, J. C., Shah, M. H., Ito, T., Bohas, C. L., Wolin, E. M., Van Cutsem, E., Hobday, T. J., Okusaka, T., Capdevila, J., de Vries, E. G. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009290 · Cited by 2,876
(2020) · PubMed · Cited by 2,642
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
Raymond, E., Dahan, L., Raoul, J.-L., Bang, Y.-J., Borbath, I., Lombard-Bohas, C., Valle, J., Metrakos, P., Smith, D., Vinik, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1003825 · Cited by 2,567
Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
Timmerman, R. (2010) · JAMA · doi:10.1001/jama.2010.261 · Cited by 2,532
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-2-201207170-00459 · Cited by 2,522
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
Lim, H., Devesa, S. S., Sosa, J. A., Check, D., & Kitahara, C. M. (2017) · JAMA · doi:10.1001/jama.2017.2719 · Cited by 2,159
Edwards, B. K., Ward, E., Kohler, B. A., Eheman, C., Zauber, A. G., Anderson, R. N., Jemal, A., Schymura, M. J., Lansdorp‐Vogelaar, I., Seeff, L. C., et al. (2010) · Cancer · doi:10.1002/cncr.24760 · Cited by 2,002
Self-citationThe Effect of Advances in Lung-Cancer Treatment on Population Mortality
Howlader, N., Forjaz, G., Mooradian, M. J., Meza, R., Kong, C. Y., Cronin, K. A., Mariotto, A. B., Lowy, D. R., & Feuer, E. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916623 · Cited by 1,712
Self-citationInternational Classification of Diseases for Oncology
Trott, P. A. (1977) · Journal of Clinical Pathology · doi:10.1136/jcp.30.8.782-c · Cited by 1,676
Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults
Moore, S. C., Lee, I.-M., Weiderpass, E., Campbell, P. T., Sampson, J. N., Kitahara, C. M., Keadle, S. K., Arem, H., Berrington de Gonzalez, A., Hartge, P., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.1548 · Cited by 1,487
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Grossman, D. C., Curry, S. J., Owens, D. K., Bibbins-Domingo, K., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Ebell, M., Epling, J. W., et al. (2018) · JAMA · doi:10.1001/jama.2018.3710 · Cited by 1,436
Edwards, B. K., Noone, A., Mariotto, A. B., Simard, E. P., Boscoe, F. P., Henley, S. J., Jemal, A., Cho, H., Anderson, R. N., Kohler, B. A., et al. (2014) · Cancer · doi:10.1002/cncr.28509 · Cited by 1,210
Self-citationDiabetes and Cancer: A Consensus Report
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20078 · Cited by 1,055
Tobacco product use among adults—United States, 2019.
Cornelius, M. E., Wang, T. W., Jamal, A., Loretan, C. G., & Neff, L. J. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6946a4 · Cited by 975
Davis, A. A., & Patel, V. G. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0768-9 · Cited by 960
Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
Tsilidis, K. K., Kasimis, J. C., Lopez, D. S., Ntzani, E. E., & Ioannidis, J. P. A. (2015) · BMJ · doi:10.1136/bmj.g7607 · Cited by 860
Type I and II Endometrial Cancers: Have They Different Risk Factors?
Setiawan, V. W., Yang, H. P., Pike, M. C., McCann, S. E., Yu, H., Xiang, Y.-B., Wolk, A., Wentzensen, N., Weiss, N. S., Webb, P. M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.2596 · Cited by 827
Versteijne, E., van Dam, J. L., Suker, M., Janssen, Q. P., Groothuis, K., Akkermans-Vogelaar, J. M., Besselink, M. G., Bonsing, B. A., Buijsen, J., Busch, O. R., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02233 · Cited by 786
Trends in Obesity Prevalence by Race and Hispanic Origin—1999-2000 to 2017-2018
Ogden, C. L., Fryar, C. D., Martin, C. B., Freedman, D. S., Carroll, M. D., Gu, Q., & Hales, C. M. (2020) · JAMA · doi:10.1001/jama.2020.14590 · Cited by 776
Sturgis, E. M., & Cinciripini, P. M. (2007) · Cancer · doi:10.1002/cncr.22963 · Cited by 756
Tobacco Product Use Among Adults — United States, 2020
Cornelius, M. E., Loretan, C. G., Wang, T. W., Jamal, A., & Homa, D. M. (2022) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7111a1 · Cited by 700 · cited 1×
“Adult smoking prevalence declined from >40% during the early 1960s to 13% in 2019.(26,27) The decline in lung cancer death rates during the most recent period, however, was more than double the decline for incidence, in part reflecting recent advances in targeted and immune therapies for non‐small cell lung cancer (NS…”
Obesity and Prostate Cancer: Weighing the Evidence
Allott, E. H., Masko, E. M., & Freedland, S. J. (2013) · European Urology · doi:10.1016/j.eururo.2012.11.013 · Cited by 601
Trends in Sedentary Behavior Among the US Population, 2001-2016
Yang, L., Cao, C., Kantor, E. D., Nguyen, L. H., Zheng, X., Park, Y., Giovannucci, E. L., Matthews, C. E., Colditz, G. A., & Cao, Y. (2019) · JAMA · doi:10.1001/jama.2019.3636 · Cited by 593
Best Practices for Comprehensive Tobacco Control Programs
Control, D. (2014) · Cited by 565
Arias, E., Schauman, W. S., Eschbach, K., Sorlie, P. D., & Backlund, E. (2008) · PubMed · Cited by 546
(2019) · PubMed · Cited by 535
Lung Cancer Screening With Low-Dose Computed Tomography in the United States—2010 to 2015
Jemal, A., & Fedewa, S. A. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.6416 · Cited by 530
Self-citationScreening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-3-200808050-00008 · Cited by 505
Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics
Islami, F., Ward, E. M., Sung, H., Cronin, K. A., Tangka, F. K. L., Sherman, R. L., Zhao, J., Anderson, R. N., Henley, S. J., Yabroff, K. R., et al. (2021) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djab131 · Cited by 478
Self-citationRecent advances in the management of lung cancer
Jones, G. S., & Baldwin, D. R. (2018) · Clinical Medicine · doi:10.7861/clinmedicine.18-2-s41 · Cited by 463
Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer
Chavez-MacGregor, M., Clarke, C. A., Lichtensztajn, D. Y., & Giordano, S. H. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.3856 · Cited by 370
Missed Opportunities: Racial Disparities in Adjuvant Breast Cancer Treatment
Bickell, N. A., Wang, J. J., Oluwole, S., Schrag, D., Godfrey, H., Hiotis, K., Mendez, J., & Guth, A. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5799 · Cited by 363
Racial Disparities in Treatment and Survival Among Women With Early-Stage Breast Cancer
Hershman, D., McBride, R., Jacobson, J. S., Lamerato, L., Roberts, K., Grann, V. R., & Neugut, A. I. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.633 · Cited by 308
Health Disparities and Triple-Negative Breast Cancer in African American Women: A Review
Newman, L. A., & Kaljee, L. M. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2017.0005 · Cited by 304
Clarke, M. A., Devesa, S. S., Harvey, S. V., & Wentzensen, N. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.00151 · Cited by 299
Incidence of Breast Cancer in the United States: Current and Future Trends
Anderson, W. F., Katki, H. A., & Rosenberg, P. S. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr257 · Cited by 285
The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women
Cote, M. L., Ruterbusch, J. J., Olson, S. H., Lu, K., & Ali-Fehmi, R. (2015) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0316 · Cited by 272
Age-Specific Incidence of Melanoma in the United States
Paulson, K. G., Gupta, D., Kim, T. S., Veatch, J. R., Byrd, D. R., Bhatia, S., Wojcik, K., Chapuis, A. G., Thompson, J. A., Madeleine, M. M., et al. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2019.3353 · Cited by 229
Palmer, J. R., Viscidi, E., Troester, M. A., Hong, C.-C., Schedin, P., Bethea, T. N., Bandera, E. V., Borges, V., McKinnon, C., Haiman, C. A., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju237 · Cited by 203
Jim, M. A., Arias, E., Seneca, D. S., Hoopes, M. J., Jim, C. C., Johnson, N. J., & Wiggins, C. L. (2014) · American Journal of Public Health · doi:10.2105/ajph.2014.301933 · Cited by 199
Self-citationLiebler, C. A., Porter, S. R., Fernandez, L. E., Noon, J. M., & Ennis, S. R. (2017) · Demography · doi:10.1007/s13524-016-0544-0 · Cited by 190
Diabetes and Cancer: Risk, Challenges, Management and Outcomes
Shahid, R. K., Ahmed, S., Le, D., & Yadav, S. (2021) · Cancers · doi:10.3390/cancers13225735 · Cited by 187
Pfeiffer, R. M., Webb-Vargas, Y., Wheeler, W., & Gail, M. H. (2018) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0098 · Cited by 178
Cho, B., Han, Y., Lian, M., Colditz, G. A., Weber, J. D., Ma, C. X., & Liu, Y. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.1254 · Cited by 161
Liu, L., Shi, Y., Li, T., Qin, Q., Yin, J., Pang, S., Nie, S., & Wei, S. (2016) · British Journal of Sports Medicine · doi:10.1136/bjsports-2015-094728 · Cited by 158
Impact of Overweight and Obesity on US Papillary Thyroid Cancer Incidence Trends (1995–2015)
Kitahara, C. M., Pfeiffer, R. M., Sosa, J. A., & Shiels, M. S. (2020) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz202 · Cited by 142 · cited 1×
“Prior studies have shown increases in both incidence and death rates of distant‐stage thyroid cancer from the 1990s to the early 2010s,(86,87) suggesting that there is a genuine increase in the risk of thyroid cancer that likely reflects changes in the prevalence of underlying risk factors, such as excess body weight.…”
Henley, S. J., Thomas, C. C., Lewis, D. R., Ward, E., Islami, F., Wu, M., Weir, H. K., Scott, S., Sherman, R., Ma, J., et al. (2020) · Cancer · doi:10.1002/cncr.32801 · Cited by 141
Self-citationUnderstanding the ever-changing incidence of thyroid cancer
Kitahara, C. M., & Sosa, J. A. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00414-9 · Cited by 140
Krieger, N., Jahn, J. L., & Waterman, P. D. (2016) · Cancer Causes & Control · doi:10.1007/s10552-016-0834-2 · Cited by 138
Jemal, A., Culp, M., Ma, J.-M., Islami, F., & Fedewa, S. (2020) · Journal of the National Cancer Institute · doi:10.1093/jnci/djaa068 · Cited by 136
Self-citationTrends and Patterns in Menarche in the United States: 1995 through 2013-2017.
Martinez, G. M. (2020) · National health statistics reports · Cited by 131
Espey, D. K., Jim, M. A., Richards, T. B., Begay, C. L., Haverkamp, D. S., & Roberts, D. (2014) · American Journal of Public Health · doi:10.2105/ajph.2013.301716 · Cited by 110
The Changing Landscape of Gynecologic Cancer Mortality in the United States
Giaquinto, A. N., Broaddus, R. R., Jemal, A., & Siegel, R. L. (2022) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004676 · Cited by 107
Self-citationAge at Menarche: 50-Year Socioeconomic Trends Among US-Born Black and White Women
Krieger, N., Kiang, M. V., Кошелева, А., Waterman, P. D., Chen, J. T., & Beckfield, J. (2014) · American Journal of Public Health · doi:10.2105/ajph.2014.301936 · Cited by 101
Lung Cancer Screening Rates During the COVID-19 Pandemic
Fedewa, S. A., Bandi, P., Smith, R. A., Silvestri, G. A., & Jemal, A. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.07.030 · Cited by 101
Self-citationObesity and mortality in men with locally advanced prostate cancer: Analysis of RTOG 85‐31
Efstathiou, J. A., Bae, K., Shipley, W. U., Hanks, G. E., Pilepich, M. V., Sandler, H. M., & Smith, M. R. (2007) · Cancer · doi:10.1002/cncr.23093 · Cited by 100
Krieger, N., Singh, N., & Waterman, P. D. (2016) · Cancer Causes & Control · doi:10.1007/s10552-016-0793-7 · Cited by 90
Genetic Susceptibility Loci for Subtypes of Breast Cancer in an African American Population
Palmer, J. R., Ruiz-Narváez, E., Rotimi, C. N., Cupples, L. A., Cozier, Y. C., Adams-Campbell, L. L., & Rosenberg, L. A. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0769 · Cited by 89
Newman, L. A., Jenkins, B. D., Chen, Y., Oppong, J. K., Adjei, E. K., Jibril, A. S., Hoda, S. A., Cheng, E., Chitale, D. A., Bensenhaver, J. M., et al. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003459 · Cited by 85
Mortality Profile of the Non-Hispanic American Indian or Alaska Native Population, 2019
Arias, E., Xu, J., Curtin, S. C., Bastian, B. A., & Tejada‐Vera, B. (2021) · doi:10.15620/cdc:110370 · Cited by 84
Neighborhood Social Environmental Factors and Breast Cancer Subtypes among Black Women
Qin, B., Babel, R. A., Plascak, J. J., Lin, Y., Stroup, A. M., Goldman, N., Ambrosone, C. B., Demissie, K., Hong, C., Bandera, E. V., et al. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1055 · Cited by 80
Linnenbringer, E. L., Geronimus, A. T., Davis, K. L., Bound, J., Ellis, L., & Gomez, S. L. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05545-1 · Cited by 78
Incidence rates of exocrine and endocrine pancreatic cancers in the United States
Zhou, J., Enewold, L., Stojadinovic, A., Clifton, G. T., Potter, J. F., Peoples, G. E., & Zhu, K. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9512-y · Cited by 75
Ambrosone, C. B., Zirpoli, G., Hong, C., Yao, S., Troester, M. A., Bandera, E. V., Schedin, P. S., Bethea, T. N., Borges, V. F., Park, S., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv172 · Cited by 72
Barber, L. E., Zirpoli, G., Cozier, Y. C., Rosenberg, L. A., Petrick, J. L., Bertrand, K. A., & Palmer, J. R. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01483-y · Cited by 62
Warnecke, R. B., Campbell, R. T., Vijayasiri, G., Barrett, R. E., & Rauscher, G. H. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0945 · Cited by 58
The Rise and Fall of Cancer Mortality in the USA: Why Does Pancreatic Cancer Not Follow the Trend?
Ma, J., & Jemal, A. (2013) · Future Oncology · doi:10.2217/fon.13.76 · Cited by 54
Self-citationAdedokun, B., Du, Z., Gao, G., Ahearn, T. U., Lunetta, K. L., Zirpoli, G., Figueroa, J. D., John, E. M., Bernstein, L., Zheng, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24327-x · Cited by 47
Liu, Y., Colditz, G. A., Kozower, B., James, A., Greever-Rice, T., Schmaltz, C., & Lian, M. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.1040 · Cited by 42
Chollet‐Hinton, L., Olshan, A. F., Nichols, H. B., Anders, C. K., Lund, J. L., Allott, E. H., Bethea, T. N., Hong, C., Cohen, S. M., Khoury, T., et al. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0450 · Cited by 36
Bertrand, K. A., Bethea, T. N., Adams-Campbell, L. L., Rosenberg, L. A., & Palmer, J. R. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0692 · Cited by 34
Progress and Opportunities in Tobacco Control
Cokkinides, V. E., Bandi, P., Ward, E. M., Jemal, A., & Thun, M. J. (2006) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.3.135 · Cited by 28
Self-citationComparing Cancer Registry Abstracted and Self-Reported Data on Race and Ethnicity.
Atekruse, S. F., Cosgrove, C. M., Cronin, K. A., & Yu, M. (2017) · PubMed · Cited by 26
Self-citationDisparities in timely treatment among young women with breast cancer
Jain, U., Jain, B., Fayanju, O. M., Chino, F. L., & Dee, E. C. (2022) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2022.01.019 · Cited by 25
Structural Racism and Triple-Negative Breast Cancer Among Black and White Women in the United States
Eldridge, L., & Berrigan, D. A. (2022) · Health Equity · doi:10.1089/heq.2021.0041 · Cited by 24
Sakaguchi, T., Satoi, S., Yamamoto, T., Yamaki, S., & Sekimoto, M. (2020) · Surgery Today · doi:10.1007/s00595-020-01963-2 · Cited by 16
Cited by
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21708 · Cited by 17,196
Self-citationPancreatic cancer: Advances and challenges
Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M., & Maitra, A. (2023) · Cell · doi:10.1016/j.cell.2023.02.014 · Cited by 1,321
Prevalence of cancer survivors in the United States
Tonorezos, E., Devasia, T., Mariotto, A. B., Mollica, M. A., Gallicchio, L., Green, P., Doose, M., Brick, R., Streck, B., Reed, C., et al. (2024) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djae135 · Cited by 290
High-throughput PRIME-editing screens identify functional DNA variants in the human genome
Ren, X., Yang, H., Nierenberg, J. L., Sun, Y., Chen, J., Beaman, C., Pham, T., Nobuhara, M., Takagi, M. A., Narayan, V., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.11.021 · Cited by 70
Cahoon, E. K., Mandal, S., Pfeiffer, R. M., Wheeler, D. C., Sargen, M. R., Alexander, B. H., Kitahara, C. M., Linet, M. S., & Mai, J. Z. (2024) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djae186 · Cited by 10
Metadata
- Authors
- Cronin, K. A., Scott, S., Firth, A. U., Sung, H., Henley, S. J., Sherman, R. L., Siegel, R. L., Anderson, R. N., Kohler, B. A., Benard, V. B., Negoita, S., Wiggins, C., Cance, W. G., & Jemal, A.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2022-10-27
- Volume
- 128
- Issue
- 24
- Pages
- 4251-4284
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W4307381352
- Cited by
- 557
- References
- 82
- FWCI
- 44.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.